Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Generics company Vensun raises $22.5mm in Series C round

02 Dec 2016

Executive Summary

Vensun Pharmaceuticals Inc. (generic drugs) raised $22.5mm in its Series C financing round. The round was led by Perceptive Advisors, and included participation from new investor Deerfield Management, along with existing investors JW Asset Management, company management, and entities affiliated with Dr. Allen Chao, the co-founder of Watson Pharmaceuticals. Michael Altman of Perceptive was appointed to Vensun's Board.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By